Navigation Links
Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
Date:6/1/2010

SAN DIEGO, June 1, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that Christian Weyer, MD has been appointed Senior Vice President, Research and Development. Orville Kolterman, MD, has been named Senior Vice President, Chief Medical Officer. These leadership changes will strengthen the Company's focus on preparations for a new product launch and the advancement of its late-stage development programs, both important value drivers for the Company.

During his 10-year tenure at Amylin, Dr. Weyer has made valuable contributions to the business through leadership roles in the Research, Clinical, and Corporate Development organizations, most recently as Vice President, Medical Development. In his new role, Dr. Weyer will lead Amylin's R&D organization, focusing on expanding opportunities with the Company's existing diabetes products, advancing the obesity and early diabetes pipeline, and driving research programs that support innovation and business growth.

Dr. Kolterman was previously Senior Vice President, Research and Development. In the newly created role of Chief Medical Officer, Dr. Kolterman will work to further strengthen Amylin's ties with the medical community, policy-makers, patient advocacy groups, and other audiences that will be critical in supporting the successful launch of BYDUREON™ (exenatide for extended-release injectable suspension) and driving therapeutic innovation for patients. Dr. Kolterman will also continue to lead interactions with regulatory agencies and have responsibility for global safety activities.

"The changes announced today will sharpen Amy
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
2. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
3. Amylin Pharmaceuticals to Webcast Year-End Financial Results
4. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
5. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals Reports Third Quarter Financial Results
8. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
9. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
10. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
11. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer") ... to divest in the United States ... Discovery® Elbow System assets and Cobalt™ bone cement assets.  ... acquisition of Biomet, Inc. ("Biomet").  , ... the Bureau of Competition Staff of the U.S. Federal ...
(Date:5/28/2015)... , May 28, 2015  Pharmaceutical companies ... drugs and tests, and this is translating ... that can assist them. This according to Kalorama ... said instruments such as mass spectrometry, electrophoresis ... the identification of drug targets and the ...
(Date:5/28/2015)... May 28, 2015  Maetrics ( http://maetrics.com ), a ... sector, wrapped up a successful conference, "The cost of ... industry," today in Zurich . ... and its Switzerland -based team, experts ... Medical Technology field to an exclusive local audience. The ...
Breaking Medicine Technology:Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE Amex: ... specialty pharmaceuticals company in China, today announced financial results for ... ThirdQ uarter Highlights Revenue increased ... quarter of fiscal year 2009 Excluding an adjustment for ...
... USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino -- BOSTON, November 11, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, ...
Cached Medicine Technology:China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 2China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 3China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 4China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 5China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 6China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 7China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 8China Pharma Holdings, Inc. Reports Third Quarter 2010 Financial Results 9EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 2EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 3EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 4EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 5EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 6EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 7EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino 8
(Date:5/28/2015)... Are policies that spell out when Medicare pays ... pain for seniors? That’s what a study published this ... to figure out, and its findings could have implications ... study, “Observation Encounters and Subsequent Nursing Facility Stays,” ... Medicare policies that distinguish between an “inpatient” hospital stay ...
(Date:5/28/2015)... 2015 The Paw Project, ... dramatic billboard intended to educate the Oregon public about ... busy intersection of Market Street and Park Avenue in ... You’re for De-clawing Cats, Raise Your Hand,” depicts a ... joint, providing a graphic and anatomically-correct representation of the ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 " Trends Investing ... Biz Report, which takes a look at small, medium, and ... the host of NewsWatch and business expert, conducted the business ... guides users to where they should invest their money. , ... sound concept. But doing it and knowing how to ...
(Date:5/28/2015)... FL (PRWEB) May 28, 2015 Nidra Herbal ... incredibly gentle on the body. A non-addictive supplement, Nidra Herbal ... blend of natural ingredients will leave users with a real ... system of care , Ayurveda, which translates as the “Science ... than 5,000 years ago and is a holistic system of ...
(Date:5/28/2015)... May 28, 2015 Healthpointe is ... now be offering Echocardiography Examinations to patients with ... by renowned Qualified Medical Examiner and licensed Cardiologist, ... test is a non-invasive and cost-effective approach to ... critically ill or have undergone surgery. Also ...
Breaking Medicine News(10 mins):Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 2Health News:Declawing is Cruel, Education is the Key - Says the Paw Project 3Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:Ayurveda Herba Corp’s Revolutionary Herbal Sleep Supplement is Now Available from Amazon.com 2Health News:Healthpointe Is Now Offering Echocardiography Examinations at the Anaheim Clinic. 2
... to Enhance Patient Safety, Efficiency, SAN RAMON, ... global services firm that specializes in enabling,transformation of ... it has signed a $1.5 million five-year contract ... that includes 331 skilled nursing,facilities and 19 assisted ...
... 29 Sun Pharmaceutical Industries,Ltd. (Reuters: SUN.BO, Bloomberg: ... letter to Barrie Levitt, M.D., Chairman of Taro ... purported,termination of the May 18, 2007 merger agreement ... Director of Sun, said, "Taro is,not entitled to ...
... time makes ovaries lose their ability to produce estrogens ... In this stage, when menstruation cesses, there appear physical ... dryness, articulation and bone pain, headaches, insomnia, sadness, depression ... Spain, the average age for the cessation of the ...
... Winning Entries From Oncology on Canvas(SM) To Be On ... is Not a Dress,Rehearsal," "More Than a Statistic," "Why ... represented in art and narrative at an exhibit,featuring selected ... a Cancer Journey Art Competition and Exhibition. The art ...
... Stress, hormone imbalances to blame for a condition many women suffer ... ... day, women worldwide,look in the mirror, and where they used to see ... hair loss, they try,to hide it with make-up, creative hairstyles, or sometimes ...
... INDIANAPOLIS, May 29 People who favor,flip-flops as ... lower leg pain and a change in their stride, ... of the American College,of Sports Medicine (ACSM) in Indianapolis., ... with the observation,that most people appear to be wearing ...
Cached Medicine News:Health News:Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company 2Health News:Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 2Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 4Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 5Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 6Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 7Health News:Post-menopausal therapy to improve women's quality of life 2Health News:Art Exhibit Honors National Cancer Survivors Day 2Health News:Art Exhibit Honors National Cancer Survivors Day 3Health News:Hair Loss Is on the Rise, and Women Are Among the Hardest Hit 2Health News:Flip-Flops, Heels Examined for Performance, Impact 2Health News:Flip-Flops, Heels Examined for Performance, Impact 3